Page 3 - Amanda Sheldon News Today

WESTLAKE VILLAGE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the U.S.

Arcutis to receive $30 million upfront payment and is eligible to receive potential development and commercial milestone payments, as well as double digit tiered royalties WESTLAKE VILLAGE, Calif. and HANGZHOU, China, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, and Hangzhou Zhongmei Huadong Pharmaceutical Co, a wholly owned subsidiary of Huad

Arcutis to receive $30 million upfront payment and is eligible to receive potential development and commercial milestone payments, as well as double digit...

WESTLAKE VILLAGE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical...

The debate continues over whether local school libraries should remove books that some parents consider to be obscene or pornographic.

Janelle Cuthbertson documents her experience at Port Adelaides 2023 pre-season camp.

FinancialContent fully hosted finance channel

WESTLAKE VILLAGE, Calif., June 06, 2023 -- Arcutis Biotherapeutics, Inc. , an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced... | June 10, 2023

WESTLAKE VILLAGE, Calif., June 05, 2023 -- Arcutis Biotherapeutics, Inc. , an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in... | June 5, 2023

First novel steroid-free topical with a new mechanism of action approved for plaque psoriasis in over 25 yearsFirst ZORYVE approval outside of the U.S. marks key milestone for Arcutis WESTLAKE... | April 28, 2023